|
[18F]FluorThanatrace Clinical Trials
2 actively recruiting trials across 1 location
▼ -1 trial since August 2026
Also known as: [18F]FTT
Pipeline
Phase 1: 1
Top Sponsors
- Abramson Cancer Center at Penn Medicine2
Indications
- Cancer2
- Neuroendocrine Carcinoma Metastatic1
- Prostate Cancer Metastatic1
- Pancreatic Tumors1
Philadelphia, Pennsylvania2 trials
FTT PET/CT in Metastatic Prostate Cancer
University of Pennsylvania Hospital
FTT PET/CT in Pancreatic Neuroendocrine Tumors
University of Pennsylvania, Perelman Center for Advanced Medicine
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.